Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease.
- 2003-08-07
- RCT · n = 15
- Respirology (Carlton, Vic.) 8(3)
- Seiichi Nakamura
- Yasushi Hashimoto
- Masashi Mikami
- Eiichi Yamanaka
- Tomoyuki Soma
- Mitsunori Hino
- Arata Azuma
- Shoji Kudoh
- PubMed: 12911824
- DOI: 10.1046/j.1440-1843.2003.00482.x
- High evidence
- Clinical
After 4 weeks of SER treatment, sputum weight in the morning ... significantly decreased.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 30 mg/day